127 related articles for article (PubMed ID: 31218958)
21. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
22. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
Wanajo A; Sasaki A; Nagasaki H; Shimada S; Otsubo T; Owaki S; Shimizu Y; Eishi Y; Kojima K; Nakajima Y; Kawano T; Yuasa Y; Akiyama Y
Gastroenterology; 2008 Aug; 135(2):580-90. PubMed ID: 18588891
[TBL] [Abstract][Full Text] [Related]
23. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression.
Yuan K; Ye J; Liu Z; Ren Y; He W; Xu J; He Y; Yuan Y
J Exp Clin Cancer Res; 2020 Jan; 39(1):9. PubMed ID: 31928530
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of long non-coding RNA HOXD-AS1 inhibits gastric cancer cell growth via inactivating the JAK2/STAT3 pathway.
Zheng L; Chen J; Zhou Z; He Z
Tumour Biol; 2017 May; 39(5):1010428317705335. PubMed ID: 28475004
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
26. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
27. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
28. DERL3 functions as a tumor suppressor in gastric cancer.
Li Y; Liu H; Chen H; Shao J; Su F; Zhang S; Cai X; He X
Comput Biol Chem; 2020 Feb; 84():107172. PubMed ID: 31862624
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
30. PRAME as a Potential Biomarker for Liver Metastasis of Gastric Cancer.
Baba H; Kanda M; Sawaki K; Umeda S; Miwa T; Shimizu D; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y; Fujii T
Ann Surg Oncol; 2020 Jun; 27(6):2071-2080. PubMed ID: 31659640
[TBL] [Abstract][Full Text] [Related]
31. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
32. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
[TBL] [Abstract][Full Text] [Related]
35. Level of Melanotransferrin in Tissue and Sera Serves as a Prognostic Marker of Gastric Cancer.
Sawaki K; Kanda M; Umeda S; Miwa T; Tanaka C; Kobayashi D; Hayashi M; Yamada S; Nakayama G; Omae K; Koike M; Kodera Y
Anticancer Res; 2019 Nov; 39(11):6125-6133. PubMed ID: 31704840
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
[TBL] [Abstract][Full Text] [Related]
37. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
38. Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL.
Liu B; Zhang Y; Fan Y; Wang S; Li Z; Deng M; Li C; Wang J; Ma R; Wang X; Wang Y; Xu L; Hou K; Che X; Liu Y; Qu X
Cancer Sci; 2019 Jul; 110(7):2145-2155. PubMed ID: 31087525
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer.
Shiozaki A; Ariyoshi Y; Iitaka D; Kosuga T; Shimizu H; Kudou M; Konishi T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Ichikawa D; Otsuji E
Gastric Cancer; 2019 May; 22(3):473-485. PubMed ID: 30191346
[TBL] [Abstract][Full Text] [Related]
40. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]